Treatment of transient hypothyroxinemia of prematurity: A survey of neonatal practice

Journal of Perinatology

Volumn 22, Issue 7, 2002, Pages 563-565

  Golombek, Sergio G ^a   LaGamma, Edmund F ^a   Paneth, Nigel ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROXINE;

ARTICLE; CLINICAL PRACTICE; DOSE RESPONSE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROXINEMIA; MEDICAL SPECIALIST; NEONATOLOGY; NEWBORN CARE; NEWBORN MORTALITY; PREMATURITY; THYROID DISEASE;

HEALTH CARE SURVEYS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PERINATOLOGY; PHYSICIAN'S PRACTICE PATTERNS; THYROID HORMONES; THYROXINE;

EID: 0036773232     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210791     Document Type: Article

References (14)

1. Reuss ML, Leviton A, Paneth N, Susser M. Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation. Am J Public Health 1997;87(10):1693-7, also NEJM letter.
2. Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M. The relation of transient hypothyxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996;334:821-7.
3. den Ouden AL, Kok JH, Verkerk PH, Brand R, Verloove-Vanhorick SP. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in national cohort of very preterm and/or very low birthweight infants. Pediatr Res 1996;39:142-5.
4. Lucas A, Rennie J, Baker BA, Morley R. Low plasma triiodothyronine concentrations and outcome in preterm infants. Arch Dis Child 1988;63:1201-6.
5. Lucas A, Morley R, Fewtrell MS. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 years follow up. BMJ 1996;312:1132-3.
6. Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the preterm infant: The benefits and risk of thyroxine treatment. J Pediatr 2001;139(2):182-8.
7. United States Neonatologist and Perinatologists Directory. Section on Perinatal Pediatrics - AAP - CD - 1998.
8. Schonberger W, Grimm W, Emmrich P, et al. Reduction in mortality rate in premature infants by substitution of thyroid hormones. Eur J Pediatr 1981; 135:245-53.
9. Chowdry P, Scanlon JW, Auerbach R, Abassi V. Result of a controlled double-blind study of thyroid replacement in very-low-birth-weight premature infants with hypothyroxinemia. Pediatrics 1984;73:301-5.
10. Vanhole C, Aerssens P, Naulaers G, et al. L-Thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatr Res 1997;42:87-92.
11. Van Wassenaer AG, Kok JH, Endert E. et al. Effects of thyroxine supplementation on neurological development in infants born at less than 30 weeks gestation. N Engl J Med 1997;336:21-6.
12. Osborn DA. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. Cochrane Database Syst Rev 2000;(4):CD001070.
13. Amato M, Pasquier S, Carasso A, van Muralt G. Postnatal thyroxine administration for idiopathic respiratory distress syndrome in premature infants. Horm Res 1988;29:27-30.
14. Amato M, Guggisberg C, Schneider H. Postnatal triiodothyronine replacement and respiratory distress syndrome of the preterm infant. Hporm Res 1989;32:213-7.